United States· US:65219-276_fdf858c8-71c8-4870-8e5f-baaeb54cde6d
Succinylcholine Chloride
A medicinal product containing succinylcholine chloride dihydrate, registered in United States by Fresenius Kabi USA LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SUCCINYLCHOLINE CHLORIDE DIHYDRATE
- Manufacturer
- Fresenius Kabi USA LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1165219-276-10
- ndc11652192761010 SYRINGE, PLASTIC in 1 CARTON (65219-276-10) / 10 mL in 1 SYRINGE, PLASTIC (65219-276-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Succinylcholine chloride dihydrate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSUXAMETHONIUM CHLORID VUABVUAB Pharma a.s., Roztoky
- United KingdomAnectine 100mg/2ml solution for injection ampoulesAspen Pharma Trading Ltd
- Japanスキサメトニウム塩化物水和物
- GermanyLysthenonEvolan Pharma Ab
- FinlandSukolinOrion Corporation
- SwedenCelocurin 50 mg/ml Injektionsvätska, lösningViatris AB
- NetherlandsSuxamethoniumchloride CF 50 mg/ml, injectievloeistofCentrafarm B.V.
- NorwayLysthenonTakeda
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Lysthenon, Suxamethonium Aguettant
- Belgium · Celocurine, Suxamethonium Chloride Ethypharm
- Bulgaria · Листенон, Суксаметониум
- Cyprus · Suxamethonium Chlorid Vuab
- Czechia · Suxamethonium Chlorid Vuab, Suxamethonium Chloride Panpharma
- Germany · Lysthenon, Succinylcholin Inresa
- Denmark · Suxamethonium Chloride Aguettant, Suxamethonium Chloride Dihydrate Ethypharm
- Estonia · Lysthenon
- Spain · Suxametonio Ethypharm, Zennux
- Finland · Sukolin, Suxamethonium Aguettant
- France · Celocurine, Suxamethonium Aguettant
- United Kingdom (Northern Ireland) · Suxamethonium Chloride Martindale Pharmaceuticals, Suxamethonium Chloride Medsurge Healthcare Uk
- Greece · Lycitrope
- Ireland · Murexal, Suxamethonium Chloride Ethypharm
- Italy · Musrelan
- Lithuania · Lysthenon
- Luxembourg · Celocurine
- Latvia · Lysthenon
- Netherlands · Suxamethoniumchloride Cf, Suxamethoniumchloride Ethypharm
- Norway · Suxamethonium Chloride Aguettant, Suxamethonium Chloride Dihydrate Ethypharm
- Poland · Chlorsuccillin
- Portugal · Suxametónio Aguettant, Suxametónio Labesfal
- Romania · Lysthenon, Suxametonium Clorura Aguettant
- Sweden · Celocurin, Suxamethonium Aguettant
- Slovakia · Suxamethonium Chlorid Vuab, Suxamethonium Chloride Panpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1b4f7dc-7f2a-45a7-a623-da5dc7a97f0d GET /v1/drugs/d1b4f7dc-7f2a-45a7-a623-da5dc7a97f0d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "20",
"substance": "SUCCINYLCHOLINE CHLORIDE DIHYDRATE",
"productndc": "65219-276",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA217885",
"marketing_category": "ANDA"
}See everything about succinylcholine chloride dihydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.